Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Methods Find Exp Clin Pharmacol ; 18(10): 685-92, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9121225

ABSTRACT

Regional cerebral blood flow (rCBF) in 75 patients with arterial hypertension and symptoms of chronic ischemic cerebrovascular disorders was studied by using the 133Xenon infusion technique and a 30-detector setup. A baseline decrease in the mean hemispheric blood flow (rCBFh) with elevated deviations of rCBF from rCBFh were observed in the hemispheres. A single oral dose of either nifedipine or nicardipine induced various changes in rCBF. The drug effects regarding changes in the mean value of the hemispheric blood flow and the flow distribution were classified into 4 types. A decrease in the deviation of rCBF from the hemispheric mean CBF accompanied by an increase in the total brain blood flow was considered to be the most beneficial drug effect. This positive reaction was found more frequently when patients were given nicardipine. In some patients both drugs induced nonbeneficial changes in rCBF with an increase in the number of ischemic and hyperemic regions. It was hypothesized that such variants of drug effects may result in the deterioration of brain perfusion, contributing to development of focal brain ischemic damages. The effects of drugs were similar after both single doses and 2-week monotherapy. It is suggested that the analysis of drug effects on regional CBF distribution may be useful for estimating clinical importance of changes in cerebral hemodynamics during antihypertensive therapy.


Subject(s)
Calcium Channel Blockers/pharmacology , Cerebrovascular Circulation/drug effects , Hypertension/drug therapy , Nicardipine/pharmacology , Nifedipine/pharmacology , Adult , Aged , Blood Pressure/drug effects , Brain Ischemia/complications , Brain Ischemia/drug therapy , Brain Ischemia/physiopathology , Calcium Channel Blockers/therapeutic use , Female , Humans , Hypertension/complications , Hypertension/physiopathology , Male , Middle Aged , Nicardipine/therapeutic use , Nifedipine/therapeutic use
2.
Fiziol Zh SSSR Im I M Sechenova ; 77(9): 67-75, 1991 Sep.
Article in Russian | MEDLINE | ID: mdl-1666615

ABSTRACT

In arterial hypertension, cerebral blood flow (CBF) in patients with chronic cerebrovascular diseases is lower than in patients without hypertension. In stenosis of internal carotid arteries, hypertension leads to the disturbance of the response of resisting cerebral vessels compensating the decrease of perfusion pressure at the expense of vessel dilation. As compared with patients without hypertension, the difference between the values of regional CBF (rCBF) in various regions of the brain is more obvious with the appearance of alternate hypoemic and hyperemic regions. After nifedipine, both an increase and a decrease of hemispheric CBF is possible in these patients. In many of them such changes in CBF are combined with further increase of the difference between rCBF values in various parts of the brain with the formation of well marked zones with relative ischemia and hyperemia.


Subject(s)
Cerebrovascular Circulation/physiology , Hypertension/physiopathology , Blood Flow Velocity/drug effects , Blood Flow Velocity/physiology , Carotid Arteries/drug effects , Carotid Arteries/physiopathology , Carotid Artery Diseases/drug therapy , Carotid Artery Diseases/physiopathology , Cerebrovascular Circulation/drug effects , Humans , Hypertension/drug therapy , Intracranial Arteriosclerosis/drug therapy , Intracranial Arteriosclerosis/physiopathology , Middle Aged , Nifedipine/pharmacology , Nifedipine/therapeutic use , Vascular Resistance/drug effects , Vascular Resistance/physiology , Xenon Radioisotopes
4.
Article in Russian | MEDLINE | ID: mdl-1661487

ABSTRACT

It is shown that in patients with cerebral circulatory disorders, the prostacyclin -thromboxane balance is replaced toward the latter one. As a result of nifedipine administration part of the test subjects demonstrate a rise of the content of prostacyclin and a decline of the concentration of thromboxane. This effect of nifedipine is ascertained to be in a good agreement with its action on blood inflow to the brain and platelet aggregation. It is concluded that the efficacy of nifedipine can be raised if it is combined with the drugs that enhance the synthesis of prostacyclins in the body.


Subject(s)
6-Ketoprostaglandin F1 alpha/blood , Cerebral Infarction/physiopathology , Cerebrovascular Circulation/physiology , Epoprostenol/blood , Intracranial Arteriosclerosis/physiopathology , Nifedipine/therapeutic use , Thromboxane A2/blood , 6-Ketoprostaglandin F1 alpha/antagonists & inhibitors , Acute Disease , Aged , Cerebral Infarction/drug therapy , Cerebrovascular Circulation/drug effects , Humans , Intracranial Arteriosclerosis/drug therapy , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...